From: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
Number of relapses
Groups
Study group
Number (%)
Control group
0
18 (90)
0 (0)
1
2 (10)
11 (36.6)
2
19 (63.3)